<DOC>
	<DOC>NCT00465257</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy of artesuante + amodiaquine four years after its introduction as first line treatment for uncomplicated childhood malaria in Zanzibar. The hypothesis is that the treatment has a polymerase chain reaction (PCR)adjusted parasitological cure rate of at least 85% 42 days after treatment.</brief_summary>
	<brief_title>Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction in Zanzibar</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<criteria>Age below 60 months Weight ≥5kg No general danger signs or severe malaria present (see 4.4.2.1 &amp; 4.4.2.2) History of fever within 24 hours OR axillary temperature ≥ 37.5Cº No other cause of fever is detectable No severe malnutrition Presence of P. falciparum asexual parasite density between 2000 200,000/ul Guardian/Patient has understood the procedures of the study and is willing to participate Patient able to come for stipulated follow up visits and has easy access to the Study Site Not able to drink or breastfeed Persistent Vomiting Recent history of convulsions Lethargic or unconscious Unable to sit or stand (as appropriate for age) History of allergy to test drugs History of intake of any drugs other than paracetamol and aspirin within 3 days</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>